Paroxetine cuts tamoxifen effectiveness in breast cancerOntario study links the drug combo with increased mortality Statins benefit leukemia patientsClinical trials needed to pinpoint ideal candidates Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Wait times for diagnosis exceed accepted targets FPs should take lead in reducing breast cancer risk Online tool helps family doctors screen women to detect higher-risk patients Rethinking breast cancer Chemo- trastuzumab combo ups survival Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist First Previous 65 66 67 68 69 Next Last
